FBB
LLY icon

Fulton Breakefield Broenniman’s Eli Lilly LLY Stock Holding History

Fulton Breakefield Broenniman’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36M Sell
30,025
-537
-2% -$549K 2.12% 11
2026
Q1 		$28.1M Sell
30,562
-25
-0.1% -$25.3K 1.83% 16
2025
Q4 		$32.9M Sell
30,587
-9,001
-23% -$8.61M 2.07% 15
2025
Q3 		$30.2M Sell
39,588
-901
-2% -$670K 1.95% 15
2025
Q2 		$31.6M Sell
40,489
-143
-0.4% -$111K 2.13% 15
2025
Q1 		$33.6M Sell
40,632
-2,008
-5% -$1.67M 2.42% 12
2024
Q4 		$32.9M Sell
42,640
-75
-0.2% -$62.1K 2.35% 11
2024
Q3 		$37.8M Sell
42,715
-965
-2% -$868K 2.64% 11
2024
Q2 		$39.5M Sell
43,680
-248
-0.6% -$198K 2.92% 7
2024
Q1 		$34.2M Sell
43,928
-12,056
-22% -$8.58M 2.63% 10
2023
Q4 		$32.6M Sell
55,984
-653
-1% -$381K 2.63% 10
2023
Q3 		$30.4M Sell
56,637
-806
-1% -$415K 2.64% 9
2023
Q2 		$26.9M Sell
57,443
-11,233
-16% -$4.71M 2.23% 12
2023
Q1 		$23.6M Sell
68,676
-1,055
-2% -$356K 2.03% 13
2022
Q4 		$25.5M Buy
69,731
+112
+0.2% +$39.7K 2.26% 11
2022
Q3 		$22.5M Sell
69,619
-10,748
-13% -$3.41M 2.11% 13
2022
Q2 		$26.1M Sell
80,367
-8,476
-10% -$2.54M 2.25% 9
2022
Q1 		$25.4M Buy
88,843
+1,185
+1% +$305K 2.24% 12
2021
Q4 		$24.2M Buy
87,658
+1,455
+2% +$369K 1.79% 18
2021
Q3 		$19.9M Sell
86,203
-551
-0.6% -$136K 1.71% 21
2021
Q2 		$19.9M Sell
86,754
-41,242
-32% -$8.28M 1.7% 23
2021
Q1 		$23.9M Buy
127,996
+22,721
+22% +$4.44M 2.21% 12
2020
Q4 		$17.8M Sell
105,275
-15,425
-13% -$2.3M 2.13% 13
2020
Q3 		$17.9M Buy
120,700
+24,443
+25% +$3.78M 2.01% 19
2020
Q2 		$15.8M Buy
96,257
+3,750
+4% +$576K 1.92% 21
2020
Q1 		$12.8M Buy
92,507
+3,029
+3% +$416K 1.92% 20
2019
Q4 		$11.8M Buy
89,478
+1,055
+1% +$122K 1.37% 31
2019
Q3 		$9.89M Buy
+88,423
New +$9.84M 1.26% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fulton Breakefield Broenniman's LLY Position: Q2 2026 in Review

Fulton Breakefield Broenniman reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $549K and leaving 30,025 shares worth $36M. The position accounts for 2.12% of the portfolio, ranked #11.

Fulton Breakefield Broenniman first reported a position in LLY in Q3 2019 and has held it in 28 quarters since. The position peaked at $39.5M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fulton Breakefield Broenniman held 30,025 shares of Eli Lilly worth $36M as of Q2 2026.
  • Fulton Breakefield Broenniman sold 537 Eli Lilly shares in Q2 2026, an estimated $549K.
  • Eli Lilly made up 2.12% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #11 holding.
  • Fulton Breakefield Broenniman first reported a position in Eli Lilly in Q3 2019 and has held it in 28 quarters since.
  • Fulton Breakefield Broenniman's Eli Lilly position peaked at $39.5M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.